Sep 23, 2026 04:45AM

Sep 14, 2026 07:46AM

Aug 18, 2026 04:15AM

Jun 16, 2026 05:17AM

Apr 27, 2026 01:58AM

Apr 15, 2026 08:08AM

Apr 8, 2026 04:35PM TuHURA Biosciences enters $50 million at-the-market offering agreement

Apr 7, 2026 07:47AM

Mar 24, 2026 10:30AM

Mar 23, 2026 07:45AM

Feb 17, 2026 07:46AM

Feb 2, 2026 07:45AM

Dec 15, 2025 07:51AM

Dec 11, 2025 07:30AM TuHURA Biosciences raises $15.6 million in equity financing

Dec 8, 2025 07:50AM

Nov 14, 2025 07:50AM

Nov 3, 2025 09:02AM

Aug 22, 2025 06:58AM

Jul 1, 2025 08:50AM

Jun 30, 2025 08:51AM

Jun 30, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on TuHURA Biosciences (HURA)

Jun 24, 2025 08:04AM

Jun 23, 2025 05:02PM

Jun 23, 2025 09:16AM

Jun 9, 2025 10:12AM

Jun 9, 2025 08:01AM

Jun 3, 2025 10:00AM

May 5, 2025 08:06AM TuHURA Biosciences (HURA) Initiates Phase 1b/2a Study of IFx-Hu2.0 as an Adjunctive Therapy to Keytruda in First Line Treatment for MCCUP

Apr 28, 2025 08:04AM

Apr 7, 2025 08:25AM

Apr 3, 2025 06:45AM

Mar 11, 2025 08:05AM

Mar 10, 2025 09:00AM

Feb 19, 2025 09:00AM

Dec 19, 2024 05:48AM Rodman & Renshaw Starts TuHURA Biosciences (HURA) at Buy

Dec 13, 2024 01:21PM

Dec 12, 2024 08:46AM

Dec 12, 2024 08:45AM

Nov 25, 2024 08:39AM

Nov 25, 2024 08:35AM

Oct 23, 2024 08:30AM

Oct 22, 2024 09:00AM TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event

Oct 17, 2024 04:38PM

Oct 17, 2024 04:35PM

468,193 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All